Exploring novel therapeutic strategies: Could psychedelic perspectives offer promising solutions for Alzheimer's disease comorbidities?
Dialogues Clin Neurosci March 19, 2025 DOI: 10.1080/19585969.2025.2480566
Summary
Psychedelic compounds may offer new hope for Alzheimer's patients by addressing both cognitive decline and mental health challenges. Research shows that certain psychedelics can promote neural plasticity and reduce inflammation while simultaneously helping with depression and anxiety - common issues in Alzheimer's. Early findings suggest these compounds could provide a dual-therapeutic approach, potentially improving both brain health and emotional wellbeing.
Abstract
Exploring novel therapeutic strategies: Could psychedelic perspectives offer promising solutions for Alzheimer's disease comorbidities?